Back to 
LOOMIS SAYLES & CO L P
LOOMIS SAYLES & CO L P
SNDX1 quarters
Position history for LOOMIS SAYLES & CO L P's holdings in SYNDAX PHARMACEUTICALS INC
Yes. Loomis Sayles holds 923,624 shares of SNDX (Syndax Pharmaceuticals), worth $20.2M, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$20.2M
Current Shares
923,624
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of SNDX: WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc., BlackRock Finance, Inc.